Live Breaking News & Updates on Vaccine Emergency Use
Stay updated with breaking news from Vaccine emergency use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccines approved! SII, Bharat Biotech get DCGI nod for restricted use in emergency situation SII Pune has submitted safety immunogenicity and efficacy data generated on 23,745 participants, The overall vaccine efficacy was found to be 70.42 per cent. Share Via Email | A+A A- DGCI has accepted the govt panel s recommendation to grant restricted emergency use authorization to Covishield, Covaxin. Express News Service NEW DELHI: V G Somani, Drug Controller General of India (DCGI) on Sunday announced that the recommendations of a government-appointed panel to grant restricted emergency use authorization to Covid-19 vaccines by Serum Institute of India and Bharat Biotech in the country are being accepted. ....
Oxford COVID-19 Vaccine, Bharat Biotech s Covaxin Get Final Approval By Drug Regulator, Will Be India s First Vaccines Jan 03, 2021, 11:56 IST The Drugs Controller General of India (DCGI) provided Emergency Use Authorization (EUA) to two vaccines in India. The announcement was made earlier today. First was Covishield by Oxford-AstraZeneca and manufactured by Serum Institute of India and another one to get EUA was Covaxin by Bharat Biotech. There were multiple COVID-19 vaccines developed by different manufacturers but these two were given EUA first. DCGI’s Doctor V.G. Somani confirmed that, “Vaccines of Serum Institute of India and Bharat Biotech are granted permission for restricted use in emergency situations.” ....
Transcripts for CNN CNN Tonight with Don Lemon 20201217 08:17:15 archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.